JUBLPHARMA Jubilant Pharmova Ltd. — Smart-Money Activity, F&O Buildup & Bulk Deals
Sector: HealthcareLive setups screens JUBLPHARMA is on right now — tap to see every stock matching
Smart Money Verdict synthesis of derivatives, deals, and promoter files
Analysis what the data is telling us about JUBLPHARMA
Jubilant Pharmova Ltd. did not have meaningful F&O activity in the last completed session. That doesn't mean the stock is irrelevant — it just means the smart-money signals here come from cash markets and corporate disclosures, covered below.
There have been no notable bulk or block deals from FIIs, mutual funds, or insurance companies in Jubilant Pharmova Ltd. over the last 30 sessions.
Putting it together, the smart-money picture for Jubilant Pharmova Ltd. lacks a clear directional bias.
F&O Positioning EOD derivatives setup
Quote Details key metrics & weights
Technical Snapshot from 400 sessions of price history
Key Fundamentals headline ratios · Healthcare
Fundamental ratios sourced from public market data, refreshed periodically; verify against company filings before relying on them.
Institutional Deals last 30 sessions (bulk & block)
Insider & Promoter Filings last 60 days
Latest News recent coverage from Reuters, Simply Wall St, MT Newswires and others
JUBLPHARMA — frequently asked questions
What is the Jubilant Pharmova Ltd. share price today?
JUBLPHARMA is trading at ₹1,007.80 (-1.57% vs previous close), per the latest update on this page.
What is the P/E ratio of Jubilant Pharmova Ltd.?
JUBLPHARMA (Jubilant Pharmova Ltd.) has a trailing twelve-month P/E ratio of 40.2.
What is the market cap of Jubilant Pharmova Ltd.?
JUBLPHARMA has a market capitalisation of approximately ₹15,962 crore.
What is the ROE of Jubilant Pharmova Ltd.?
JUBLPHARMA has a return on equity (ROE) of about 6.0%.
Is JUBLPHARMA near its 52-week high?
JUBLPHARMA is trading -19.2% from its 52-week high of ₹1,248.00 as of 2026-07-21.
What is the RSI of JUBLPHARMA?
The 14-day RSI of JUBLPHARMA is 58.1, which is considered neutral.
Is JUBLPHARMA above its 200-day moving average?
JUBLPHARMA is trading above its 200-DMA of ₹994.12 (+1.4% away).
Are FIIs or big investors buying JUBLPHARMA?
Strota tracks every bulk and block deal in JUBLPHARMA with named buyers and sellers, plus promoter and insider filings — the tables on this page list the most recent institutional activity as disclosed to the exchanges.